Open Access Open Access  Restricted Access Subscription Access
Cover Image

Presumed Asymptomatic Carrier Transmission, to Control Covid-19

Mohammed Ahmed Garout, Altaf A. Abdulkhaliq, Magda Ramadan Abdultawab, Rana Mohammed Garout

Abstract


Background: With the ongoing outbreak of COVID-19 around the world, it has become a worldwide health concern. Aim of study: check a cluster or presence of asymptomatic carrier with an asymptomatic transmission of COVID-19. Material &methods: In our study check for SARS-CoV-2 test by PCR for 3000 persons (we divided them in 3 groups group 1 travelers through middle east airlines (1850), group 2 health care worker  who expose to positive cases  or on the same accommodation building (500)--, group 3 individual requested to check up to rolled out  SARS-CoV-2 either companies or individual families and families of positive cases (650)  laboratory test  a complete blood count &CRP, Nasopharyngeal swab specimens had been collected  ,All samples were processed at clinical laboratory of hospital and sent to MOH regional laboratory simultaneously laboratory confirmation by RT-PCR assay. Resluts: Among these 3000 personness, 582 were positive for COV-19, among group 1, 295 were positive 15.94%, group 2, 148 were positive 29.8%, group 3, 139 were positive 21.28% ,35  presented symptoms after admission and were defined as asymptomatic patients ; during  Conclusions Infectivity of some asymptomatic SARS-CoV-2 carriers might be weak. Effective prevention and control measures are helpful to prevent COVID-19 spread of asymptomatic carriers. The result of this study may alleviate parts of the public concern about asymptomatic infected people further longitudinal surveillance of these asymptomatic cases via virus nucleic acid testing are warranted.


Keywords


COVID-19, SARS-CoV-2, Asymptomatic carrier, Incubation period.

Full Text:

PDF

References


Lescure F.X., Bouadma L., Nguyen D. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect. Dis. 2020;20 doi: 10.1016/S1473-3099(20)30200-0. Published Online March 27 2020. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

Adalja A.A., Toner E., Inglesby T.V. JAMA; 2020. Priorities for the US Health Community Responding to COVID-19. Published Online March 03 2020. Available at: [PubMed] [CrossRef] [Google Scholar]

McCloskey B., Zumla A., Ippolito G. Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma. Lancet. 2020; 395:1096–1099. doi: 10.1016/S0140-6736(20)30681-4. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

World Health Organization. 2020. Coronavirus Disease (COVID-19) Outbreak.https://www.who.int/emergencies/diseases/novel-coronavirus-2019 Available at: [Google Scholar]

Lu R., Zhao X., Li J. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395:565–574. doi: 10.1016/S0140-6736(20)30251-8. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

Wang Y., Wang Y., Yan Chen. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J. Med. Virol. 2020;92(6):568–576. doi: 10.1002/jmv.25748. Published Online March 05 2020. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

World Health Organization Corona-virus disease (COVID-19) technical guidance: laboratory testing for 2019-nCoV in humans. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/laboratory-guidance

Del Rio C., Malani P.N. JAMA; 2020. COVID-19-New Insights on a Rapidly Changing Epidemic. Published Online February 28 2020. Available at: [PubMed] [CrossRef] [Google Scholar]

Zeng G., Xie S.Y., Li Q. Infectivity of severe acute respiratory syndrome during its incubation period. Biomed. Environ. Sci. 2009;22(6):502–510. doi: 10.1016/S0895-3988(10)60008-6. [PMC free article] [PubMed] [CrossRef] [Google Scholar]

World Health OrganizationLaboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases (2020)

Hu Z., Song C., Xu C. Life Sci; 2020. Clinical Characteristics of 24 Asymptomatic Infections with COVID-19 Screened Among Close Contacts in Nanjing, China. Sci China. Published Online March 04 2020. Available at: [PMC free article] [PubMed] [CrossRef] [Google Scholar] published in the BMJ Journal Thorax on Thursday found asymptomatic cases of Covid-19 meant the prevalence of the virus was likely to be significantly underestimated on cruise ships

Zou L., Ruan F., Huang M. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. N. Engl. J. Med. 2020;382:1177–1179. doi: 10.1056/NEJMc2001737. Available at: [PMC free article] [PubMed] [CrossRef] [Google Scholar]

Huang C., Wang Y., Li X. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395:497–506. doi: 10.1016/S0140-6736(20)301847. [PMC free article] [PubMed] [CrossRef] [Google Scholar

Guan W.J., Zhong N.S. Clinical characteristics of covid-19 in China. N. Engl. J. Med. 2020:382. doi: 10.1056/NEJMoa2002032. [PubMed] [CrossRef] [Google Scholar]

Salehi S., Abedi A., Balakrishnan S. Coronavirus disease 2019 (COVID-19): a systematic review of imaging findings in 919 patients. AJR Am. J. Roentgenol. 2020:1–7. doi: 10.2214/AJR.20.23034. [PubMed] [CrossRef] [Google Scholar]

https://www.who.int/publications-detail/laboratory-testing-for-2019-novel-coronavirus-in-suspected-human-cases-20200117 [Cited 12 March 2020]

www.thermofisher.com/us/en/home/global/terms-and-conditions.html.


Refbacks

  • There are currently no refbacks.